Exact Mass: 263.2011

Exact Mass Matches: 263.2011

Found 17 metabolites which its exact mass value is equals to given mass value 263.2011, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

triapenthenol

1-cyclohexyl-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol

C15H25N3O (263.1998)


   

Lisdexamfetamine

(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide

C15H25N3O (263.1998)


Lisdexamfetamine (L-lysine-d-amphetamine) is a prodrug of the psychostimulant d-amphetamine coupled with the essential amino acid L-lysine. It was developed so that the amphetamine psychostimulant is released and activated more slowly as the prodrug molecule is hydrolyzed consequently cleaving off the amino acid-during the first pass through the intestines and/or the liver. Amphetamines target the trace amine-associated receptor 1 (TAAR1). Amphetamine is also believed to exert its effects by binding to the monoamine transporters (the dopamine transporter or DAT) and increasing extracellular levels of the biogenic amines dopamine, norepinephrine (noradrenaline) and serotonin. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C29728 - Anorexiant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   

Recainam

N-(2,6-Dimethylphenyl)-n-{3-[(propan-2-yl)amino]propyl}carbamimidate

C15H25N3O (263.1998)


   

(5aS,7S,8bS)-8-butyl-2,3,3a,4,5,5a,6,7-octahydro-2-imino-7-methylcyclopenta[de]quinazolin-8b(1H)-ol|8bbeta-hydroxyptilocaulin

(5aS,7S,8bS)-8-butyl-2,3,3a,4,5,5a,6,7-octahydro-2-imino-7-methylcyclopenta[de]quinazolin-8b(1H)-ol|8bbeta-hydroxyptilocaulin

C15H25N3O (263.1998)


   

Farnesyl Alcohol Azide

12-azido-3,7,11-trimethyldodeca-2E,6E,10E,-trien-1-ol

C15H25N3O (263.1998)


   

Lisdexamfetamine

(2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide

C15H25N3O (263.1998)


N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C29728 - Anorexiant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators

   
   

4-[4-(2-METHOXY-PHENYL)-PIPERAZIN-1-YL]-BUTYLAMINE

4-[4-(2-METHOXY-PHENYL)-PIPERAZIN-1-YL]-BUTYLAMINE

C15H25N3O (263.1998)


   

Recainam

1-(2,6-dimethylphenyl)-3-[3-(propan-2-ylamino)propyl]urea

C15H25N3O (263.1998)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

4-isopropylamino-1-[(4-Methoxypyridine-3-)methyl]piperidine

4-isopropylamino-1-[(4-Methoxypyridine-3-)methyl]piperidine

C15H25N3O (263.1998)


   

N,N-Bis(2,2-diethoxyethyl)methylamine

N,N-Bis(2,2-diethoxyethyl)methylamine

C13H29NO4 (263.2096)


   

(1S)-2-[(2S,5R)-2-(Aminomethyl)-5-prop-1-YN-1-ylpyrrolidin-1-YL]-1-cyclopentyl-2-oxoethanamine

(1S)-2-[(2S,5R)-2-(Aminomethyl)-5-prop-1-YN-1-ylpyrrolidin-1-YL]-1-cyclopentyl-2-oxoethanamine

C15H25N3O (263.1998)


   

(8Z,11Z,14Z)-heptadecatrienoate

(8Z,11Z,14Z)-heptadecatrienoate

C17H27O2- (263.2011)


An unsaturated fatty acid anion that is the conjugate base of (8Z,11Z,14Z)-heptadecatrienoic acid, arising from deprotonation of the carboxy group.

   

N-Butyl-N-(tert-butyldimethylsilyl)aniline

N-Butyl-N-(tert-butyldimethylsilyl)aniline

C16H29NSi (263.2069)


   

9-butyl-6-imino-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8(12)-en-9-ol

9-butyl-6-imino-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8(12)-en-9-ol

C15H25N3O (263.1998)


   

(1s,4r,10s,12s)-9-butyl-6-imino-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-12-ol

(1s,4r,10s,12s)-9-butyl-6-imino-10-methyl-5,7-diazatricyclo[6.3.1.0⁴,¹²]dodec-8-en-12-ol

C15H25N3O (263.1998)